http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0865791-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2eb84eabb33a184477bc90767646d589
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1242
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102
filingDate 1998-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d424c62cd56caf63cd5c154381220b4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef77a6112875c7a438ae481351d59406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8283e3ccfb0645497f50e8bddd2b766f
publicationDate 1998-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0865791-A1
titleOfInvention Use of Pasteurella haemolytica serotype A6 for the preparation of a vaccine against cattle pasteurellosis caused by Pasteurella haemolytica
abstract (a) le surnageant, éventuellement concentré, d'une culture bactérienne denPasteurella haemolytica sérotype A6, (b) un extrait contenant des antigènes capsulaires de Pasteurella haemolyticansérotype A6, et (c) des corps bactériens entiers de Pasteurella haemolytica sérotype A6,nledit surnageant, ledit extrait et lesdits corps bactériens étant biologiquement inactivés. Bovine pasteurellosis vaccine due to Pasteurella haemolytica, characterized in that it comprises a first antigenic substance comprising at least one element chosen from the group consisting of: (a) the supernatant, possibly concentrated, of a bacterial culture of Pasteurella haemolytica serotype A6, (b) an extract containing capsular antigens of Pasteurella haemolytica serotype A6, and (c) whole bacterial bodies of Pasteurella haemolytica serotype A6, said supernatant, said extract and said bacterial bodies being biologically inactivated.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03037367-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100954175-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20040366-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03037367-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1942181-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2481393-C2
priorityDate 1997-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2023420-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8000412-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226432635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438

Total number of triples: 33.